WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
41.47
+0.37 (+0.90%)
At close: 4:15PM EST
Stock chart is not supported by your current browser
Previous Close41.10
Open40.61
Bid41.23 x 0
Ask41.47 x 0
Day's Range39.80 - 42.91
52 Week Range19.77 - 76.68
Volume2,466,842
Avg. Volume4,574,992
Market Cap14.213B
Beta (3Y Monthly)2.42
PE Ratio (TTM)N/A
EPS (TTM)-2.39
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est66.83
  • Canopy Growth best way to play Canadian cannabis
    CNBC Videos5 days ago

    Canopy Growth best way to play Canadian cannabis

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.

  • 5 Things That Really Matter When Investing in Marijuana Stocks
    Motley Fool8 hours ago

    5 Things That Really Matter When Investing in Marijuana Stocks

    Hint: Peak production potential isn't one of them.

  • Hemp! Hemp! Hooray! Congress Passes the Farm Bill
    Motley Fool11 hours ago

    Hemp! Hemp! Hooray! Congress Passes the Farm Bill

    There's now a clear path to legalizing hemp and hemp-derived CBD in the U.S. Here's what that really means.

  • This Tiny Marijuana Stock Could Be Better Prepared for the Coming Supply Glut Than Canopy Growth and Tilray
    Motley Fool11 hours ago

    This Tiny Marijuana Stock Could Be Better Prepared for the Coming Supply Glut Than Canopy Growth and Tilray

    When the going gets tough in the Canadian marijuana market, there could be a surprising winner.

  • Better Buy: Canopy Growth vs. Cronos Group
    Motley Foolyesterday

    Better Buy: Canopy Growth vs. Cronos Group

    Big deals for both of these marijuana producers have excited investors. But which stock will be the bigger winner down the road?

  • Hemp Is on the Brink of U.S. Legalization: Is Canopy Growth Positioned to Profit?
    Motley Foolyesterday

    Hemp Is on the Brink of U.S. Legalization: Is Canopy Growth Positioned to Profit?

    Congress passed the Farm Bill this week, which President Trump is expected to sign, opening the floodgates for rapid growth in the hemp-derived CBD product market in the U.S.

  • This Small-Cap Cannabis Stock Is Up Big in a Down Market. Here's Why.
    Motley Fool2 days ago

    This Small-Cap Cannabis Stock Is Up Big in a Down Market. Here's Why.

    Medical Marijuana's stock has started to heat up. Here's why.

  • ACCESSWIRE2 days ago

    Marijuana Stocks Rally After Farm Bill Boost

    CORAL GABLES, FL / ACCESSWIRE / December 14, 2018 / For marijuana stocks and those that trade them, the most recent announcements surrounding the US Farm Bill this week have become somewhat of a catalyst for the industry. Not only has it caused a stir with US pot stocks but Canadian marijuana stocks are also seeing more activity this week. With marijuana stocks in focus, here are 4 pot stocks to watch this month.

  • Market Realist2 days ago

    Tilray Invests in ROSE LifeScience

    On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec. The agreement between Tilray’s subsidiary High Park Farms and ROSE LifeScience entails an exclusive sale, distribution, supply, and marketing agreement. Tilray will spend 7.5 million Canadian dollars, which accounts for 12% in capital for ROSE LifeScience.

  • Cannabis Companies Get Serious about Niche Product Development
    Market Realist2 days ago

    Cannabis Companies Get Serious about Niche Product Development

    For a long time, we’ve discussed how product differentiation will be key to the success of cannabis producers (HMMJ) in such a crowded market. Companies within the cannabis space know this very well and are making early moves to develop and acquire intellectual property rights from other companies to be able to develop unique products that may someday be a blockbuster for the companies. On December 3, Canopy Growth (WEED) announced a multiyear agreement with Valens GroWorks (MYMSF).

  • Aphria Stock Fell 9% on December 13
    Market Realist2 days ago

    Aphria Stock Fell 9% on December 13

    After the significant decline in Aphria’s (APHA) value last week, the company provided some respite to investors by purchasing shares worth $3.1 million. The company announced a special committee that consists of independent directors who will review the allegations that led Aphria’s downfall. On December 13, Aphria stock fell ~9.5% to 7.04 Canadian dollars.

  • Tilray Announced Its International Advisory Board
    Market Realist2 days ago

    Tilray Announced Its International Advisory Board

    International markets are becoming more important for cannabis companies (MJ). Tilray (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), and Cronos Group (CRON) each have international operations, as you can see in the following chart.

  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of CGC.TO earnings conference call or presentation 14-Nov-18 1:30pm GMT

    Q2 2019 Canopy Growth Corp Earnings Call

  • Cronos Group: Which Firms Upgraded the Target Price?
    Market Realist3 days ago

    Cronos Group: Which Firms Upgraded the Target Price?

    Following Altria’s news, Cronos Group (CRON) received target price upgrades from notable investment management companies. On average, four companies (MJ) upgraded Cronos Group’s target price by nearly 70%.

  • Canopy Growth announces multi-year extraction agreement with Valens GroWorks
    CNW Group3 days ago

    Canopy Growth announces multi-year extraction agreement with Valens GroWorks

    SMITHS FALLS, ON , Dec. 13, 2018 /CNW/ - Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth" or the "Company") announces today that it has entered into a multi-year extraction agreement with Valens GroWorks Corp. (VGW.CN) (MYMSF) ("Valens"), a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification. Under the terms of the multi-year agreement, Valens will utilize their proprietary technology and methodologies to process the Company's whole flower and trim into high-grade cannabis resin.

  • Cronos Group: Optimism in the Cannabis Industry
    Market Realist3 days ago

    Cronos Group: Optimism in the Cannabis Industry

    In the last three days, Cronos Group (CRON) generated optimism in the cannabis industry (HMMJ). The market was wary about Aphria (APHA). Cronos Group’s optimism was fueled by Altria’s stake in the company.

  • Canadian Cities Voted against Private Cannabis Retail Stores
    Market Realist3 days ago

    Canadian Cities Voted against Private Cannabis Retail Stores

    On December 12, Mississauga and Markham voted against opening private cannabis retail stores for now. The Mississauga city council voted 10-2 against allowing private cannabis retail stores to operate in the city. The Markham city council voted 12-1 against opening private cannabis retail stores.

  • Benzinga4 days ago

    Wells Fargo Shares Takeaways From Canopy Growth CEO's New York Presentation

    On Dec. 11, the Consumer Analyst Group of New York hosted a group luncheon where Canopy Growth Corp. (NYSE: CGC ) CEO Bruce Linton presented. Wells Fargo analysts attended the luncheon and presented their ...

  • CNBC4 days ago

    Canopy Growth CEO says Farm Bill passage is 'first step' toward US expansion

    The "Farm Bill is the first step to active" involvement in the U.S. by Canopy Growth, CEO Bruce Linton told CNBC Wednesday. The $867 billion bill, which was passed by both the U.S. Senate and House of Representatives, includes a provision for industrial hemp legalization. The legislation has been cited by numerous public cannabis companies as the catalyst to formally enter the American market, according to Cowen analyst Vivien Azer.

  • Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
    Market Realist4 days ago

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer, the widely followed host of Mad Money on CNBC, gave his opinion on the deal between Cronos Group (CRON) and Altria on December 11. Cramer called Altria’s acquisition of a 45% stake in Cronos Group last week a “smart move” for Altria. This trend brings some concern for the growth trajectory of companies such as Altria.

  • New Zealand Joins the Legal Medical Cannabis Chorus
    Market Realist4 days ago

    New Zealand Joins the Legal Medical Cannabis Chorus

    On December 11, New Zealand’s government made way for medical cannabis legalization. New Zealand already allowed a few patients to access medical cannabis. The new law makes medical cannabis widely accessible to more patients.

  • GlobeNewswire5 days ago

    Looking at The CBD Pet Market Opportunity: Canopy Growth Corporation, CannTrust Holdings, EnviroTechnologies International (OTC:ETII), Isodiol International

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, releases a snapshot looking at the growing opportunity for the CBD pet market and how companies that are positioned in the cannabis space are adding pet markets to their growing portfolios. According to the American Pet Products Association (APPA), $69.51 billion was spent on pets in the U.S in 2017 and it’s estimated that number will grow to $72.13 billion for 2018. Canadians spend $6.6 billion a year on their pets according to recent numbers.

  • ACCESSWIRE5 days ago

    This Unknown Gold Stock Might Be The Next Big Ecuadorian Discovery. Should You Be Long?

    Lightning strikes in the markets can come in the form of a partnership or investment from larger established companies. It's also a top way to find validation for mining companies. Ecuador is a hotbed of investment activity right now, and a few small juniors have found big validation from majors in the region.